Provisional Agenda
(Subject to change)
All times mentioned refer to British Standard (BST) – London/GMT +01:00.
World Time Converter: https://www.worldtimebuddy.com
DAY 1 Wednesday 25 August
1200: Welcome by Anna Nekaris and Rita de Cassia Collaco
Keynotes: Chair Anna Nekaris
1210: Keynote 1: Camilla Whittington
The University of Sydney, School of Life and Environmental Sciences, NSW, Australia
The genetic basis of innovation: the evolution of platypus venom
1240: Keynote 2: Taline Kazandjian
Centre for Snakebite Research & Interventions, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK
The influence of defensive venom spitting on snake venom evolution
Session 1: Venom evolution: Chair Anita Malhotra
1310: Kevin Arbuckle
Department of Biosciences, College of Science, Swansea University, Swansea, UK
Radiating pain: can venom help explain why there are so many fishes and insects?
1330: Lorenzo Seneci
Venom Evolution Lab, School of Biological Sciences, University of Queensland, St Lucia, Australia
A Symphony of Destruction: Evolution and Clinical Implications of Coagulotoxicity in Rattlesnakes (Crotalus and Sistrurus)
1350: Anita Malhotra
Molecular Ecology and Evolution at Bangor, School of Natural Sciences, Bangor University, Bangor, UK & Susmita Thakur, Molecular Toxinology Laboratory, Department of Molecular Biology and Biotechnology, Tezpur University, Assam, India
Green pitvipers of the Himalayas and north-eastern India: a review of their taxonomy, venom, and clinical effects of snakebite
1410: Lee Jones
Venom Evolution Lab, School of Biological Sciences, The University of Queensland, St. Lucia, Australia
Not Goanna Get Me: Mutations in the Savannah Monitor Lizard (Varanus exanthematicus) Nicotinic Acetylcholine Receptor Confer Reduced Susceptibility to Sympatric Cobra Venom
1430: Nick Casewell
Centre for Snakebite Research & Interventions, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK
Is the spatial heterogeneity of toxin distribution observed in snake venom glands the result of adaptation or constraint?
1450: Keynote 3: Baldomero Olivera: Chair David Warrell
School Of Biological Sciences, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA
Correlating Venom Components with Prey Capture Behaviour
Session 2: Marine toxins: Chair David Warrell
1520: Richard J Harris
Venom Evolution Lab, School of Biological Sciences, The University of Queensland, St. Lucia, Australia
Getting stoned: Characterisation of the coagulotoxic and neurotoxic effects of reef stonefish (Synanceia verrucosa) venom
1540: Andrew D Turner
Centre for Environment Fisheries and Aquaculture Science (Cefas), Barrack Road, Weymouth, Dorset, UK
Natural aquatic toxins, One-Health impacts and potential risk mitigation approaches in a changing world
1600: Vidal Haddad Junior: Botucatu School of Medicine, São Paulo State University, and Vice-President of the Brazilian Society of Toxinology, Brazil
Envenomation Caused By Poisonous and Venomous Aquatic Animals
1620: Anna ML Klompen
Ecology and Evolutionary Biology, University of Kansas, Lawrence, Kansas, USA
Division of (toxic) labor: Variation in venom-like gene expression and nematocyst type across functionally distinct tissues of Hydractinia symbiolongicarpus
1640: Poster Flash presentations-1: Chair Eddie Rowan
Presenters: Abukawa, AlSolaiss, Barros1, Barros2, Bekkari, Carvalho, Cerda, Espinoza, Galarza, Melendez-Martinez, Morcatty, Oliveira, Pereira, Proleón, Silva, Souza, Suntravat, Urra, Vivas
1730: End of Day 1
DAY 2 Thursday 26 August
Session 3: Toxins to drugs: Chair Eddie Rowan
0900: Raymond Norton: Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia
Venom-derived inhibitors of microglial Kv1.3 potassium channels as therapeutic leads for neuroinflammatory diseases
0920: Jamie Seymour
Division of Tropical Health and Medicine, Australian Institute of Tropical Health and Medicine, College of Public Health, James Cook University, Australia
Novel therapeutic compounds from venomous marine animals
0940: Maria P Ikonomopoulou
Madrid Institute for Advanced Studies in Food, Madrid, E28049, Spain
The anti-tumoral profile of an octopus tachykinin peptide in melanoma of BRAF mutation is mediated by the structural conformation in the neurokinin 1 receptor-binding domain
1000: Samantha Nixon
Institute for Molecular Bioscience, The University of Queensland, St Lucia, Australia
Discovery of a spider toxin with selective anthelmintic activity against human and veterinary parasites
1020: Marcus Vinicius Gomez
Biochemistry and Pharmacology, ICB, Federal University of Minas Gerais, Pampulha, Belo Horizonte, Brazil
Phα1β a new generation of analgesic drug: 15 years of research with the Phα1β toxin purified from the venom of the spider Phoneutria nigriventer
1040: Poster Flash Presentations 2: Chair Eddie Rowan
Presenters: Bourke, Daoudi, Devi, Dijkman, Goudarzi, Hamzaoui, Igci, Ivanusec, Kiouas, Ledsgaard, XiaoyaLi, Morris-C, Moussaoui, Patel, Požek, Redureau, Sørensen, Surendran, Trinh, Wildenauer, Zdenek
Session 4: Venomous animals and new venomous taxa: Chair Ronald Jenner
1130: Krzysztof Kowalski
Department of Vertebrate Zoology and Ecology, Institute of Biology, Faculty of Biological and Veterinary Sciences, Nicolaus Copernicus University, Toruń, Poland
A new venomous shrew species rediscovered
1150: Rodrigo Ligabue Braun
Department of Pharmacosciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil
My cat is poisoning me: An Agatha Kitty mystery
1210: Leah L J Fitzpatrick
Faculty of Health and Life Sciences, Oxford Brookes University, Gipsy Lane, Oxford, UK
Weird and wonderful – examining the evolution of venom within mammals
1230: Maike L Fischer
Department of Insect Symbiosis, Max-Planck-Institute for Chemical Ecology, Jena, Germany
A bug’s secrets – Characterization of toxic venom components from the African assassin bug Psytalla horrida
1250: Denise Vilarinho Tambourgi
Immunochemistry Laboratory, Butantan Institute, São Paulo, Brazil
Complement system inhibition modulates the inflammation induced by the venom of Premolis semirufa, an Amazon rainforest moth caterpillar
Keynotes: Chair David Warrell
1310: Keynote 4: Naoual Oukkache
Laboratory of Venoms and Toxins, Pasteur Institute of Morocco, Casablanca, Morocco
Scorpion envenomation in Morocco
1340: Keynote 5: SAM Kularatne
Department of Medicine, Faculty of Medicine, University of Peradeniya, Sri Lanka
Venomous bites, stings and antivenom development in Sri Lanka
1410: Lifetime achievement award Dr Ana Maria Moura da Silva: Chair Rita de Cassia Collaco
Citation by Professor David Theakston and Dr Aura Kamiguti
1420: Ana Maria Moura da Silva
Laboratório de Imunopatologia, Instituto Butantan, São Paulo, Brazil
Composition of Bothrops atrox snake venom and consequences for snakebites in the Brazilian Amazon
Session 5: Snakebite: Chair David Warrell
1440: Muhammad Hamza
Infectious Diseases and Tropical Medicine Unit, Department of Medicine, College of Health Sciences-Bayero University, Kano/Aminu Kano Teaching Hospital-Kano, Nigeria
Progress since the publication of Theakston and Warrell’s letter in 2000 entitled ‘Crisis in snake antivenom supply in Africa
1500: Michael Abouyannis
Centre for Snakebite Research & Interventions, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK
Development of a globally relevant core outcome set for snakebite clinical trials
1520: David J Williams
The World Health Organization and The Global Snakebite Initiative, Geneva, Switzerland
Progress with the WHO Roadmap
1540: Leslie M Aglanu
Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana
Groping in the Dark: Epidemiology of Snakebite in Ghana
1600: Thomas Lamb
Centre of Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, UK
The 20-minute whole blood clotting test (20WBCT) for snakebite coagulopathy
Session 6: Toxins and pathophysiology: Chair Rita de Cassia Collaco
1620: Alexis Descatha
Poisonnig center and Toxicological surveillance Unit (Head)/Clinical Data Center (CDC, Medical director), University hospital of Angers, France and Inserm U1018, Ester Unit, University of Angers, FrancePlant poisoning: when the return to nature goes wrong
1640: Ana Cristina Castro
Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San Jose, Costa Rica
Basement membrane degradation and inflammation play a role in the pulmonary hemorrhage induced by a P-III snake venom metalloproteinase
1700: Medha Sonavane
School of Pharmacy and School of Biological Sciences, University of Reading, Reading, UK
Secretome of adipose-derived mesenchymal stem cells promotes skeletal muscle regeneration following snake venom-induced damage
1720: Christina Schroeder
Center for Cancer Research, National Cancer Institute, Frederick, MD, USA
Fluorescence imaging of peripheral nerves by a NaV1.7-targeted inhibitory cystine knot peptide
1740: End of DAY 2
DAY 3 Friday 27 August
0900: Session 8: Round table discussion “Public engagement with venomous animals and Toxinology”: Chair Anna Nekaris
- Sterrin Smalbrugge (Netherlands)
- Benjamin Waldmann (Netherlands)
- Birte Bogatz (Netherlands)
- Dorothy Okemo (Kenya)
- Tea Francis (UK)
- Caitlin Henderson (Australia)
1030: Keynote-6: Juan Calvete: Chair David Warrell
Laboratorio de Venómica Evolutiva y Traslacional, Instituto de Biomedicina de Valencia, CSIC, Valencia, Spain
Mutual enlightenment: A toolbox of concepts and methods for integrating evolutionary and clinical toxinology via snake venomics and the contextual stance
Session 7: Venomics and transcriptomics: Chair Juan Calvete
1100: Fernanda Gobbi Amorim
Laboratory of Mass Spectrometry, MolSys Research Unit, University of Liège, Liège, Belgium
Next-generation sequencing for venomics: application of Multi-Enzymatic Limited Digestion for inventorying the snake venom arsenal
1120: Charlotte Dawson
Centre for Snakebite Research & Interventions, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK
Intraspecific venom variation in the medically important puff adder (Bitis arietans): comparative transcriptomics, in vitro venom activity and immunological recognition by antivenom
Keynotes: Chair Anna Nekaris
1140: Keynote 7: Bryan Fry
Venom Evolution Lab, School of Biological Sciences, University of Queensland, St Lucia, Australia
The dynamic diversification of reptile venoms
1210: Keynote 8: Cecilie Knudsen
Tropical Pharmacology Lab, DTU Bioengineering, Technical University of Denmark, Lyngby, Denmark
Advances in the development of antibody-based treatments and diagnostics for snakebite envenoming
Session 8: New Treatments for envenoming: Chair Jose M Gutierrez
1240: Abhinandan Chowdhury
Venom Evolution Lab, University of Queensland, St. Lucia, Australia
Venom-induced blood disturbances by Palearctic Viperid snakes, and their relative neutralization by antivenoms and enzyme-Inhibitors
1300: Nessrin Alomran
Centre for Snakebite Research & Interventions, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK
Mammalian cell expression of recombinant snake venom serine proteases and their use as immunogens to generate anti-toxin antibodies
1320: Ketan Patel
School of Pharmacy and School of Biological Sciences, University of Reading, Reading, UK
Small Molecule Inhibitors to treat snake venom induced muscle damage
1340: Line Ledsgaard
Department of Biotechnology and Biotherapeutics, Technical University of Denmark, Lyngby, Denmark
Antivenom unchained – Engineering antibody affinity and cross-reactivity by light chain-shuffling
1400: Matthew Lewin
Ophirex Inc, Research Division, Corte Madera, California, USA
Varespladib and antivenom combinations exhibit synergistic inhibition of sPLA2 activity in Indian ‘Big 4’ venoms
1420: Timothy P Jenkins
H.C. Ørsted COFUND, Marie Skłodowska-Curie Actions, Tropical Pharmacology & Biotherapeutics, DTU Bioengineering, Denmark
Enabling broadly-neutralising antibodies: Venom toxin clustering and unravelling snake venom complexity
Session 9: Education Seminar: Chair Bethany Moos
1440: Bethany Moos
Hedena Health, London Road, Headington, Oxford, UK
Progressing towards the WHO milestones; the development of a draft toolkit for community engagement on snakebite envenoming
1500: Gnaneswar Chandrasekharuni, Snake Conservation & Snakebite Mitigation Project, Madras Crocodile Bank Trust, Centre for Herpetology, Tamil Nadu, India
Preventing snakebites through community participation
1520: Anika Salim
School of Pharmacy and School of Biological Sciences, University of Reading, Reading, UK
Determining the knowledge gaps and training requirements among Indian healthcare professionals to improve snakebite management
1540: Sakthivel Vaiyapuri
Research and Enterprise Services, University of Reading, UK
Venomous Snakebites: Rapid Action Saves Lives – a community public health programme improves snakebite awareness, education and management in Tamil Nadu, India
1600: Manuela B Pucca
Medical School, Federal University of Roraima, Boa Vista – RR, Brazil
Snakebite Roraima: confronting a neglected health problem in the most neglected state of Brazil
1620: Announcement of Poster Prizes and Farewell
1640: End of DAY 3 and the meeting
